Pseudogout and gout cause surprisingly similar levels of pain during a flare, but they differ in important ways that make one “worse” than the other depending on what you measure. In a direct comparison, patients rated flare pain almost identically: 6.8 out of 10 for pseudogout and 6.7 out of 10 for gout. The real differences show up in how many joints get hit, how long attacks last, what treatment options exist, and what other health problems tag along.
Flare Pain Is Nearly Identical
If you’re comparing the raw pain of a single flare, neither condition clearly wins. A study published in the Journal of Rheumatology found that patients with pseudogout and gout reported virtually the same pain scores during an acute attack, with no statistically significant difference. Both groups also reported a similar sense of feeling unwell during flares.
Where the experience starts to diverge is in overall disease burden between flares. Gout patients scored significantly higher on a measure called RAPID3, which captures pain, physical function, and wellbeing together. Gout patients also reported greater concern during attacks. Pseudogout patients, by contrast, scored closer to people with mild osteoarthritis on physical function and everyday pain measures. So while a single pseudogout flare hurts just as much, the overall impact of gout on daily life tends to be heavier.
Gout Hits More Joints at Once
Gout flares involve an average of about 5 joints, compared to roughly 2 joints during a pseudogout flare. That difference is significant. A gout attack that lights up your big toe, ankle, and knee simultaneously creates a very different experience than a pseudogout flare isolated to one knee.
The two conditions also favor different parts of the body. Gout is famous for targeting the base of the big toe, though it can strike ankles, knees, wrists, and fingers. Pseudogout most commonly affects the knees, followed by wrists and ankles, and occasionally the hips or smaller joints. Because pseudogout tends to settle in larger, weight-bearing joints like the knee, it can make walking and standing particularly difficult even when only one joint is involved.
Pseudogout Flares Can Last Much Longer
A typical gout flare peaks within 12 to 24 hours and resolves within a week or two, even without treatment. Pseudogout follows a slower timeline. Attacks may take longer to reach peak intensity and can persist for up to 3 months even with treatment. That drawn-out course is one of the clearest ways pseudogout can feel worse than gout, especially for people who experience repeated episodes.
Gout Carries Greater Systemic Health Risks
Gout is not just a joint disease. It’s tightly linked to a constellation of metabolic problems that make it a marker for broader health risk. People with gout have higher rates of heart disease, high blood pressure, type 2 diabetes, heart failure, kidney disease, kidney stones, and sleep apnea compared to the general population. Gout is also closely associated with metabolic syndrome and obesity.
These connections run in both directions. High uric acid levels contribute to cardiovascular and kidney problems, while conditions like kidney disease slow uric acid clearance and make gout worse. Patients themselves have described how gout flares raise their blood pressure and worsen existing heart conditions. Pseudogout doesn’t carry this same web of metabolic associations. The crystals that cause pseudogout form through different mechanisms, often related to aging cartilage or conditions affecting calcium metabolism like overactive parathyroid glands, rather than the dietary and metabolic pathways that drive gout.
Gout Has Far Better Treatment Options
This is one of the starkest differences between the two conditions, and it actually makes pseudogout harder to manage in the long run. Gout has multiple FDA-approved medications that target its root cause by lowering uric acid levels in the blood. When uric acid stays below a certain threshold, crystal deposits gradually dissolve and flares stop. For many gout patients, the disease can be effectively controlled or even put into remission with consistent treatment.
Pseudogout has no equivalent. There is no approved drug that dissolves calcium pyrophosphate crystals or prevents them from forming. Treatment focuses entirely on managing inflammation during flares, typically with anti-inflammatory medications or joint drainage. One common anti-inflammatory used for gout flares is also used off-label for pseudogout, but it only addresses symptoms rather than the underlying crystal deposits. This means pseudogout tends to be a condition you manage rather than one you can bring under control, which for some patients makes it the more frustrating diagnosis despite causing less overall disease burden.
Different Triggers, Different Control
Gout flares have well-known dietary and lifestyle triggers. Red meat, shellfish, alcohol (especially beer), and sugary drinks can spike uric acid levels and set off an attack. That gives gout patients some degree of control through diet, hydration, and weight management, on top of medication.
Pseudogout triggers are harder to pin down and harder to avoid. Flares can follow surgery, acute illness, joint injury, or dehydration. In some cases, they seem to occur without any clear trigger at all. The crystals accumulate in cartilage over years, and their shedding into the joint space can happen unpredictably. This lack of controllable triggers is another reason pseudogout can feel more frustrating to live with, even if gout carries greater overall health consequences.
Which One Is Actually Worse
The answer depends on what you mean by “worse.” Gout involves more joints per flare, creates a higher overall disease burden, and is linked to serious conditions like heart disease and kidney damage. By those measures, gout is the more dangerous disease. But pseudogout flares can drag on for months, the condition has no targeted treatment, and patients have fewer options for preventing future attacks. For day-to-day manageability, pseudogout can be more difficult to live with precisely because there’s less you can do about it.
Both conditions affect roughly the same proportion of the population, with gout estimated at 1% to 4% and pseudogout at about 4%, though pseudogout becomes much more common with age. Neither is rare, and neither should be dismissed as a minor nuisance. The pain during a flare is equally intense regardless of which type of crystal is causing it.